Evidence map›Paper›PMID 39763979›Full record

ArticlebioRxiv : the preprint server for biology2024

Katelyn R Sheneman, Timothy D Cummins, Michael L Merchant, Joshua L Hood, Silvia M Uriarte, Matthew B Lawrenz

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Katelyn R ShenemanDepartment of Microbiology and Immunology, University of Louisville.ORCID 0000-0001-5374-5055
Timothy D CumminsDepartment of Medicine and Proteomics Technology Center, University of Louisville.ORCID 0000-0001-9648-5441
Michael L MerchantDepartment of Pharmacology and Toxicology, University of Louisville.ORCID 0000-0003-4128-4057
Joshua L HoodDepartment of Pharmacology and Toxicology, University of Louisville.ORCID 0000-0003-3998-4118
Silvia M UriarteDepartment of Oral Immunology & Infectious Disease, University of Louisville.ORCID 0000-0002-6171-0271
Matthew B LawrenzDepartment of Microbiology and Immunology, University of Louisville.ORCID 0000-0003-1505-5429

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HOOD, JOSHUA L. · 2016 to 2025
$24.1M
Iron independent role for yersiniabactin in Yersinia pestisR01AI148241 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAWRENZ, MATTHEW B · 2021 to 2025
$3.1M
Impact of inflammatory lipids on Yersinia pestis infectionR01AI178106 · NIAID · UNIVERSITY OF LOUISVILLE · PI Matthew B Lawrenz · 2023 to 2026
$2.9M
Extracellular vesicles released in response to Yersinia pestisR21AI169423 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAWRENZ, MATTHEW B, URIARTE, SILVIA M · 2022 to 2023
$430k
Defining the impact of Extracellular Vesicles on inflammation during pneumonic plagueF31AI178999 · NIAID · UNIVERSITY OF LOUISVILLE · PI SHENEMAN, KATELYN RENEE · 2023 to 2025
$107k
NIAID NIH HHS F31 AI178999NIAID NIH HHS R01 AI148241NIAID NIH HHS R01 AI178106NIAID NIH HHS R21 AI169423NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20 GM113226
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

human neutrophils (hPMNs)plaguetype 3 secretion system (T3SS)Yersinia pestisYop effectors

Identifiers

PMID39763979
PMCPMC11702605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.